Skip to content
AgilVax Logo
  • Team
  • Products
    • xCT-ADC
    • xCT-mAb
    • AX09-VLP
  • Pipeline
  • Publications
  • Cancer
    • Target
    • Focus
  • News
  • Contact
Loading...
  • Subscribe to stay informed

NewsJordan2019-04-04T16:22:09+00:00
Thu
16 Jan
2020
AgilVax Announces Expansion of Series A-1 Financing
Read More
Mon
18 Nov
2019
AgilVax to Present Positive Preclinical Data for Monoclonal Antibody Targeting xCT at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference
Read More
Thu
07 Nov
2019
AgilVax to Present at the 2019 NYC Oncology Investor Conference
Read More
Thu
25 Jul
2019
AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer
Read More
Wed
29 May
2019
AgilVax Triggers $2 Million Phase II Fast Track SBIR Grant and Initiates GMP Manufacturing
Read More
Wed
09 Jan
2019
AgilVax Elects Dr. David T. Hung, Former Founder and CEO of Medivation, to Its Board of Directors
Read More
footer-logo
Contact Us

Team

xCT-ADC

xCT-mAb

AX09-VLP

Publications

Target

Focus

News

Contact

Copyright © AgilVax 2020. Website Design and Development by Ingenuity Software Labs